tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AIM ImmunoTech’s Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsAIM ImmunoTech’s Earnings Call: Progress Amid Challenges
4M ago
AIM ImmunoTech files $100M mixed securities shelf
Premium
The Fly
AIM ImmunoTech files $100M mixed securities shelf
4M ago
AIM ImmunoTech made ‘significant strides’ over course of 2024
Premium
The Fly
AIM ImmunoTech made ‘significant strides’ over course of 2024
4M ago
AIM ImmunoTech to not proceed with offering pursuant to registration statement
PremiumThe FlyAIM ImmunoTech to not proceed with offering pursuant to registration statement
5M ago
AIM ImmunoTech announces follow-up clinical study of Ampligen with FluMist
Premium
The Fly
AIM ImmunoTech announces follow-up clinical study of Ampligen with FluMist
5M ago
AIM ImmunoTech announces Safety Committee approval to proceed with Phase 2
Premium
The Fly
AIM ImmunoTech announces Safety Committee approval to proceed with Phase 2
5M ago
AIM ImmunoTech Executives Forego Bonuses for R&D Focus
PremiumCompany AnnouncementsAIM ImmunoTech Executives Forego Bonuses for R&D Focus
7M ago
AIM ImmunoTech receives noncompliance notification from NYSE
Premium
The Fly
AIM ImmunoTech receives noncompliance notification from NYSE
7M ago
AIM ImmunoTech expands patent portfolio with new Netherlands patent
Premium
The Fly
AIM ImmunoTech expands patent portfolio with new Netherlands patent
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100